Patents Assigned to Tranxenogen
  • Anticancer peptide compositions
    Patent number: 7326679
    Abstract: The invention provides compositions and methods for inhibiting angiogenesis associated with tumors and reducing tumor growth.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: February 5, 2008
    Assignee: TranXenoGen, Inc.
    Inventors: Nathan H. Sloane, Kathleen M. Hehir, Alexander Baguisi, Paul DiTullio
  • Nuclear reprogramming using cytoplasmic extract
    Patent number: 6753457
    Abstract: The present invention concerns products and methods particularly useful for activating and analyzing non-dividing cell nuclei. The featured products include activating egg extracts, cytostatic factor (CSF) extracts, kits containing these extracts, and a microchamber microscope slide useful in analyzing nucleus activation.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: June 22, 2004
    Assignee: Tranxenogen
    Inventor: Lawrence J. Wangh